Product NDC: | 0310-7810 |
Proprietary Name: | Vandetanib |
Non Proprietary Name: | Vandetanib |
Active Ingredient(s): | 100 mg/1 & nbsp; Vandetanib |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0310-7810 |
Labeler Name: | AstraZeneca Pharmaceuticals LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022405 |
Marketing Category: | NDA |
Start Marketing Date: | 20110421 |
Package NDC: | 0310-7810-30 |
Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (0310-7810-30) |
NDC Code | 0310-7810-30 |
Proprietary Name | Vandetanib |
Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (0310-7810-30) |
Product NDC | 0310-7810 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Vandetanib |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110421 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | VANDETANIB |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |